This trial will study whether two different types of formula have different effects on the gut microbiome of critically ill children.
- Critical Illness
- Imbalance of Microbes
- Acute Lymphoblastic Leukemia (ALL) in Children.
1 Primary · 1 Secondary · Reporting Duration: Prior to initiation of enteral tube feeds then on day 1, day 5-7, and day 14 of feedings
Awards & Highlights
2 Treatment Groups
1 of 2
1 of 2
40 Total Participants · 2 Treatment Groups
Primary Treatment: Pediasure · No Placebo Group · N/A
Who is running the clinical trial?
Age 1 - 17 · All Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is this research initiative currently accepting individuals for participation?
"The clinical trial is currently accepting participants, according to details available on clinicialtrials.gov. Originally posted on February 2nd 2018, the study was last updated September 19th 2022." - Anonymous Online Contributor
How many individuals are being admitted to the trial's cohort?
"Affirmative. According to the information hosted on clinicaltrials.gov, this clinical trial is currently recruiting participants and was initially posted on February 2nd 2018. Up until September 19th 2022, 40 individuals from 1 location have been accepted into the study." - Anonymous Online Contributor
What criteria must be met to qualify as a participant in this research study?
"To be eligible for inclusion in this clinical study, potential participants must have a severe illness and fall between 1 year old and 17 years old. The aim of the trial is to recruit 40 patients." - Anonymous Online Contributor
Does the research allow for geriatric populations to join?
"This clinical trial requires participants to be aged 1 year up to 17 years. Out of the 221 different trials, 49 are specific for those below 18 and 172 target patients over 65." - Anonymous Online Contributor